Skip to content

Evaluation of Diagnostic Efficacy of the STROOP Test for Minimal Hepatic Encephalopathy

To Explore the Efficacy Evaluation of the Therapy of Nourishing Qi, Nourishing Yin, Detoxifying and Removing Blood Stasis in the Treatment of Minimal Hepatic Encephalopathy Based on STROOP Test

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055609
Enrollment
Unknown
Registered
2022-01-14
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimal hepatic encephalopathy

Interventions

Gold Standard:positive in NCT-A and DST tests
Index test:STROOP

Sponsors

Beijing Municipal Administration of Hospitals
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Nonalcoholic cirrhosis patients between 20 and 75 years of age who were consent to test for MHE according to the psychometric hepatic encephalopathy score (PHES) and the stroop test. 1. The first stage is to meet the diagnostic criteria of Western medicine for liver cirrhosis, and the liver function grades of A, B and C are all acceptable. 2. Aged 18 to 70 years; 3. In the second stage, patients diagnosed with MHE by PHES test were included. 4. Informed consenter.

Exclusion criteria

Exclusion criteria: 1. HE with clinical symptoms; 2. Previous mental abnormalities (such as severe anxiety, depression, etc.) or neurological abnormalities (sequelae of stroke, Parkinson's disease, etc.); 3. Use of anesthetics, sedatives or central nervous system depressants (other drugs such as blood-lowering ammonia drugs or branched-chain amino acids) within a month; 4. Alcoholic cirrhosis; 5. Patients with pathologic retardation (e.g., anemia, hemoglobin below 90 g/L, Water electrolyte acid-base imbalance, Temperature rise above 37.5 ?); 6. Patients with primary liver cancer; 7. Complications of upper gastrointestinal bleeding within the last 2 weeks; 8. Unable to take mental intelligence test due to educational level and visual acuity (red-green color blindness); 9. Patients with severe cardiopulmonary diseases, cerebrovascular accidents and severe diabetes complications; 10. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
receiver operating characterisic curve;sensitivity;specificity;

Countries

China

Contacts

Public ContactJiang Tingting

Beijing Ditan Hospital, Capital Medical University,

2008gezi@sina.com+86 13811020148

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026